Dale Broadrick - 13 Jun 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Issuer symbol
BRTX
Transactions as of
13 Jun 2022
Net transactions value
+$5,097
Form type
4
Filing time
15 Jun 2022, 16:45:00 UTC
Previous filing
13 Jun 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $5,097 +1,300 +0.45% $3.92 291,573 13 Jun 2022 Direct F1
holding BRTX Common Stock 316,972 13 Jun 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 125 13 Jun 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 125 13 Jun 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 13 Jun 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 13 Jun 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 13 Jun 2022 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $3.8999 to $4.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F2 Owned by Fleetco, Inc. of which reporting person is a 93% shareholder.